Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AlzeCure to present at International scientific conference

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it will have two presentations at AD/PD 2019, the 14th International Conference on Alzheimer’s & Parkinson’s Diseases, March 26-31, in Lisbon, Portugal.Märta Dahlström, who is the lead author of the study, will give her oral presentation on March 27, at 2pm WET (3pm CET).The title of it is: AC-25793, A Positive Modulator of Neurotrophin Signaling, Attenuates Scopolamine-Induced Memory Impairment and Reduces Depression-Like Symptoms in Mice. "In this study, we have within our NeuroRestore platform developed new small

CLS Presents MRI-Guided, Laser Ablation Solutions for Prostate Cancer at CME-Accredited Conferences in London, Paris & Amsterdam

Lund, Sweden – March 25, 2019 - Clinical Laserthermia Systems AB  (publ) (CLS) today announced it will be exhibiting and presenting its High Precision, Image-Guided Laser Ablation Solutions at three CME-Accredited Medical Conferences & Workshops in the UK, France, and Netherlands this April 2019. CLS Thermal Therapy products are currently in use at hospitals and clinics in the U.S. and EU for patient treatments and also undergoing several clinical trials.   “CLS is excited to be participating in these three medical education

CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019

Lund, Sweden – March 25, 2019 - Clinical Laserthermia Systems AB  (publ) (CLS)today announced that clinical studies and results for its imILT®heat-induced cancer immunotherapy for tumors will be presented during a one hour symposium at the European Conference on Interventional Oncology  (ECIO) in Amsterdam, the Netherlands this April 8-11, 2019. The company also will participate in an educational, hands-on workshop for “Tumor ablation” featuring its TRANBERG®|Thermal Therapy System 

Electrolux issues SEK 1 billion Green Bond

Electrolux is issuing the first bond loan within its green bond framework, raising SEK 1 billion to fund investments and other projects with environmental benefits.The bond is being issued under Electrolux existing EMTN (Euro Medium Term Note) program and the recently launched Electrolux Green Bond Framework. The funds raised will be used for financing or refinancing of eligible “green assets” as defined in the framework. The total principal amount of the bond is SEK 1 billion and the issue date for the bond loan will be March 27, 2019, with a maturity on March 27, 2024. The loan has a

Voucher increases for Academedia amount to 2.5% in Sweden

Voucher notifications have been recieved for almost 80 percent of the student base which gives a stable average for the Swedish operations. Average voucher increases for 2019 are for AcadeMedia’s Swedish operations estimated to 2.5 (2.5) percent and 3.4 (2.2) percent for the Norwegian preschools. The increases are in line with the figures provided in AcadeMedia's latest quarterly report. Voucher increases have been calculated based on voucher notifications received and have been weighted with AcadeMedia’s student mix in each segment. As communicated in the most recent interim report

Electrolux highlights lower emissions and investments for improved climate impact in 2018 Sustainability Report

Electrolux, the appliance industry sustainability leader, today reported a 66% reduction in CO2 emissions from its operations since 2005, and highlighted how significant investments at manufacturing sites and in new product platforms will make a major contribution to the company achieving its climate targets.In the 2018 Sustainability Report, released today, Electrolux presents facts and figures showing the company’s progress towards its targets in the nine key areas outlined in its sustainability framework, For the Better. Read the full report here: www.electroluxgroup.com/

Implementation of IFRS 16 Leases, Kesko Group’s restated comparison figures for January-December 2018

IFRS 16 Leases, which took effect on 1 January 2019, addresses the definition, recognition and measurement of lease agreements and other information given in relation to lease agreements in financial statements. According to the standard, the lessee recognises in its balance sheet right-of-use assets and financial liabilities. This release presents Kesko Group’s restated comparison figures for January-December 2018, calculated in accordance with the standard that took effect on 1 January 2019. Kesko Corporation has provided information on the implementation of IFRS 16 Leases in a 19

Share buy-backs in Nordic Waterproofing (to secure the Company’s incentive programs) during week 12, 2019

During the period March 18, 2019, until and including March 22, 2019, Nordic Waterproofing Holding A/S has repurchased in total 11,665 own shares (ISIN: DK0060738409). The share buy-backs form part of the SEK 18 million share buy-back program that Nordic Waterproofing announced on December 20, 2018, in order to secure the Company’s incentive programs. The share buy-back program, which runs between December 20, 2018, and March 29, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “

Forxiga approved in Europe for type-1 diabetes

25 March 2019 07:00 GMT Forxiga approved in Europe for type-1 diabetes Forxiga is the first oral medicine approved in Europe as an adjunct to insulin for adults with type-1 diabetes and the first AstraZeneca medicine ever approved for type-1 diabetes The European Commission (EC) has approved Forxiga (dapagliflozin) for use in type-1 diabetes (T1D) as an adjunct to insulin in patients with a BMI ≥ 27 kg/m2, when insulin alone does not provide adequate glycaemic control despite optimal insulin therapy. This is the first approval of Forxiga for the treatment of patients with T1D.

FOUNDER OF ENCARE AWARDED THE “DISTINGUISHED NUTRITION SUPPORT INTERNATIONAL SERVICE AWARD”

Professor Olle Ljungqvist, the founder of Encare, has been awarded the 2019 Distinguished Nutrition Support International Award in connection with the recently held American Society for Parenteral and Enteral Nutrition (ASPEN) Congress in Phoenix, Arizona. He was awarded “for his exceptional leadership and clinical practice contributions”. Professor Ljungqvist is also one of the founders of ERAS[®] Society (Enhanced Recovery After Surgery), www.erassociety.org, which mission is to develop perioperative care and to improve recovery through research, education, audit and implementation of

Redeye initiates coverage of Beijer Electronics Group

Redeye initiates coverage of Beijer Electronics Group, which offers a play on industrial digitalization, and has emerged from a long turnaround and is now better positioned than ever. While current valuation is fair, BELE should be attractive to long-term investors seeking industrial IoT exposure. We argue that increased profitability and an improved digitalisation positioning should justify an increased valuation over time.  Read more and download the initial research report: http://bit.ly/2WnhXtM

Elekta Unity MR-linac receives Medical Device License from Health Canada

New system for the delivery of radiotherapy using magnetic resonance imaging to enhance personalized cancer treatment in CanadaTORONTO, March 25, 2019 – Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received a Medical Device License from Health Canada, clearing the technology for commercial sales in Canada. “We are pleased to have achieved this important milestone toward making Elekta Unity available in Canada and expect that this important new treatment option will become available to patients later this year, subsequent

Targovax to hold a webcast with Q&A session

Oslo, Norway, 25 March 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that the Company on Thursday 28 March 2019 13:00 (CET) will hold a live Q&A session with Targovax's senior management. The Q&A session will streamed at Aksjeforum. Please follow this link: http://bit.ly/2HPDTd5 We welcome questions before and during the session. Please send questions in advance to contact@targovax.com (mail%20to:%20contact@targovax.com) or post them in the commentary field below the stream during

P27 banks stay committed to realizing the P27 vision after decisions by the Norwegian banking community

The collaboration, joint ambition, and strong commitment of the founding banks ensure P27 has the solid  foundation required for realising the vision of an integrated, cross-border payment system for the 27 million people living in the Nordic region.In the beginning of 2018, Project 27, or P27, came to live through a partnership of seven banks – Danske Bank, DNB, Handelsbanken, Nordea, OP Financial Group, SEB and Swedbank – with the goal of developing the world’s first ever cross-border and multi-currency payments platform for the benefit of end-users across the Nordics. In the past year,

Picosun’s high aspect ratio ALD enables 3D thin-film batteries

ESPOO, Finland, 25th March 2019 – Picosun Group, a leading supplier of advanced ALD (Atomic Layer Deposition) thin film coating technology for industrial production, reports excellent results in conformal ALD coatings for solid-state 3D thin-film batteries. Solid-state thin-film batteries are increasingly needed in portable and wearable electronics such as smartphones, tablets, smart watches, autonomous sensors, and also in implantable medical devices. These batteries have to combine small, compact size with high energy density, which is why the next step is to move away from planar

WOW air Bond Holders in advance discussions

A majority of WOW air Bond Holders and other creditors of WOW air are in advance discussions with the aim of reaching an agreement on a voluntary restructuring including an agreement of converting current debt into equity and fund the company towards long term sustainability. Further information will be given tomorrow. This information is information that WOW air hf. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 19:35 GMT on March 24, 2019.

Discussions between WOW air and Icelandair Group cancelled

Reykjavik, Iceland – March 24, 2019 Icelandair Group has decided that its possible involvement in WOW air’s operations, as announced on 20 March 2019, will not materialize. Therefore, all discussions between the parties have been cancelled. This information is information that WOW air hf. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 18:30 GMT on March 24, 2019.

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Tempe, AZ

Free youth baseball clinic to feature seven MLB AlumniColorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Tuesday, March 26th, 2019. The free clinic features former Major League Baseball players who will teach baseball skills, drills and life lessons, concluding with an autograph session and baseball giveaways for children in attendance. Players attending* include five-year MLB veteran pitcher Buddy Schultz, as well as Jamie

Lipum and Abzena sign integrated CMC agreement

Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases.Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases. Abzena will support Lipum’s anti-BSSL antibody IND program to help develop a novel therapeutic option for autoimmune inflammatory diseases,

Resolution to carry out Private Placement of NOK 20 million

Reference is made to the stock exchange announcement published by Hiddn Solutions ASA ("Hiddn" or the "Company") on 21 December 2018 regarding commitments from certain existing shareholders and new investors in the Company for a private placement of new shares in the Company raising NOK 20 million in gross proceeds (the "Private Placement"). The Company's board of directors has today resolved to carry out the Private Placement and resolved issuance of 23,845,226 new shares in the Company, each with a nominal value of NOK 0.34, at a subscription price of NOK 0.84 (the "New Shares"). The

Fred.Olsen Renewables AS concludes a GBP 400 million refinancing and reduces cost of debt

Fred. Olsen Renewables AS, a company wholly owned by Bonheur ASA, through its 51% owned subsidiary, Fred. Olsen Wind Ltd., has today signed a non-recourse project finance facility with MUFG Bank, National Australia Bank, Siemens Bank and Sumitomo Mitsui Bank Corporation, to refinance its current debt facilities. The GBP 400 million new term loan will have a tenor of approximately 13 years, extending to 2032, with margins starting at 1.4%, increasing to 1.6% in 2023 and to 1.7% in 2028. New interest rate swap contracts will be agreed to match with approximately 75% of the underlying

Frill Holding AB approved for listing on Nasdaq First North, Stockholm

STOCKHOLM, Friday, March 22, 2019, 18:00 CET   Nasdaq has today, March 22, 2019, approved Frill Holding AB (publ) ("Frill" or "the Company") for listing on Nasdaq First North. The approval is subject to the fulfilment of customary requirements. First day of trading in Frill's shares is planned to commence on March 27, 2019, under the ticker symbol "FRILL B".The floating of the company’s shares on the Nasdaq First North stock exchange market will create a robust platform for continued growth and business development. It will enable Frill to pursue opportunities in order to strengthen the

There are no items matching the current filter
There are no more items matching the current filter
Back to top